Table I.
Characteristics of patients with and without GERD after lung transplantation
| Patients with GERD | Patients without GERD | P value | |
|---|---|---|---|
| Patients | 51% | 49% | |
| Gender | .404 | ||
| Males | 28% | 41% | |
| Females | 72% | 59% | |
| Age (yrs)* | 55 (46–60) | 59 (52–63) | .165 |
| Race | .615 | ||
| Caucasian, non-Hispanic | 90% | 94% | |
| Caucasian, Hispanic | 5% | 0 | |
| African American | 5% | 6% | |
| BMI* | 24 (20–29) | 26 (24–31) | .085 |
| Lung disease | |||
| Obstructive | 67% | 76% | .521** |
| AAT deficiency | 11% | 6% | |
| Cystic fibrosis | 22% | 6% | |
| COPD | 22% | 52% | |
| Scleroderma | 11% | 0 | |
| Bronchiectasis | 0 | 6% | |
| Chronic obstructive asthma | 0 | 6% | |
| Restrictive | |||
| IPF | 33% | 24% | |
*
Data are presented as median (interquartile range).
**
Obstructive versus restrictive lung disease.
AAT, α1-Anti-trypsin; BMI, body mass index (expressed in kg/m2); COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis.